Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
26.35
-0.01 (-0.04%)
At close: Feb 27, 2026, 4:00 PM EST
26.33
-0.02 (-0.08%)
After-hours: Feb 27, 2026, 7:14 PM EST
Zenas BioPharma Market Cap
Zenas BioPharma has a market cap or net worth of $1.41 billion as of February 27, 2026. Its market cap has increased by 369.43% in one year.
Market Cap
1.41B
Enterprise Value
1.12B
1-Year Change
369.43%
Ranking
Category
Stock Price
$26.35
Market Cap Chart
Since the IPO on September 13, 2024, Zenas BioPharma's market cap has increased from $676.47M to $1.41B, an increase of 109.09%. That is a compound annual growth rate of 65.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 1.41B | -27.43% |
| Dec 31, 2025 | 1.95B | 469.46% |
| Dec 31, 2024 | 342.27M | -49.40% |
| Sep 13, 2024 | 676.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tango Therapeutics | 1.50B |
| Savara | 1.49B |
| Nanobiotix | 1.48B |
| EyePoint | 1.45B |
| Capricor Therapeutics | 1.44B |
| Vir Biotechnology | 1.43B |
| Monte Rosa Therapeutics | 1.41B |
| Immatics | 1.39B |